Complete Response Letter

migraine
Pharma

Axsome secures hard-fought FDA nod for migraine drug Symbravo

Axsome has won approval for its oral migraine drug Symbravo, which provides rapid-acting relief from acute migraine episodes.
Kevin Dunleavy Jan 31, 2025 8:18am
Photo of a chain being held together by a piece of rope

Atara hit with cell therapy clinical hold after FDA inspection

Jan 21, 2025 9:59am
red light stop light street traffic signal

Lexicon gets final FDA rejection for diabetes prospect

Dec 23, 2024 11:20am
Image of a neon sign with the word no lit up next to an unlit yes

J&J, AZ approval filings rejected by FDA

Dec 17, 2024 10:02am
Image of a neon sign with the word no lit up next to an unlit yes

FDA shoots down Intercept's bid for full approval of Ocaliva

Nov 12, 2024 2:12pm
Image of a neon sign with the word no lit up next to an unlit yes

FDA stymies Camurus' drug over 3rd-party manufacturing issues

Oct 22, 2024 9:53am